These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27454673)

  • 21. Agmatine inhibits morphine-induced drug discrimination in rats.
    Su RB; Ren YH; Liu Y; Ding T; Lu XQ; Wu N; Liu ZM; Li J
    Eur J Pharmacol; 2008 Sep; 593(1-3):62-7. PubMed ID: 18657533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled toluene vapor as a discriminative stimulus.
    Shelton KL
    Behav Pharmacol; 2007 May; 18(3):219-29. PubMed ID: 17426486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Components of drug dependence: reinforcement, discrimination and adaptation.
    Stolerman IP
    Biochem Soc Symp; 1993; 59():1-12. PubMed ID: 8192682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some guidelines for conducting research in applied behavioral pharmacology.
    van Haaren F; Weeden M
    J Appl Behav Anal; 2013; 46(2):498-506. PubMed ID: 24114163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural mechanisms of drug stimuli: experimental approaches.
    Holtzman SG; Locke KW
    Psychopharmacol Ser; 1988; 4():138-53. PubMed ID: 3293038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction to the special issue: 50th anniversary of APA Division 28: The past, present, and future of psychopharmacology and substance abuse.
    Stoops WW; Sigmon SC; Evans SM
    Exp Clin Psychopharmacol; 2016 Aug; 24(4):207-8. PubMed ID: 27454671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similarities and differences between behavioral control by drug-produced stimuli and by sensory stimuli.
    Overton DA
    Psychopharmacol Ser; 1988; 4():176-98. PubMed ID: 3293042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of human drug discrimination studies in medication development.
    Johanson CE
    NIDA Res Monogr; 1992; 119():180-4. PubMed ID: 1435976
    [No Abstract]   [Full Text] [Related]  

  • 29. Establishment of drug discrimination and drug reinforcement in different animal strains: some methodological issues.
    Meisch RA
    J Addict Dis; 1991; 10(1-2):179-87. PubMed ID: 2065116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scopolamine effects on visual discrimination: modifications related to stimulus control.
    Evans HL
    J Pharmacol Exp Ther; 1975 Oct; 195(1):105-13. PubMed ID: 810573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats.
    Solinas M; Panlilio LV; Justinova Z; Yasar S; Goldberg SR
    Nat Protoc; 2006; 1(3):1194-206. PubMed ID: 17406402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans.
    Bickel WK; Oliveto AH; Kamien JB; Higgins ST; Hughes JR
    J Pharmacol Exp Ther; 1993 Jan; 264(1):360-7. PubMed ID: 8423538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug discrimination in neurobiology.
    Colpaert FC
    Pharmacol Biochem Behav; 1999 Oct; 64(2):337-45. PubMed ID: 10515310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One hundred years of discrimination research in the Journal of Applied Psychology: A sobering synopsis.
    Colella A; Hebl M; King E
    J Appl Psychol; 2017 Mar; 102(3):500-513. PubMed ID: 28125266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys.
    Negus SS; Mello NK; Lamas X; Mendelson JH
    J Pharmacol Exp Ther; 1996 Aug; 278(2):879-90. PubMed ID: 8768743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The GABA-B antagonist 2-hydroxysaclofen reverses the effects of baclofen on the discriminative stimulus effects of D-amphetamine in the conditioned taste aversion procedure.
    Miranda F; Jiménez JC; Cedillo LN; Sandoval-Sánchez A; Millán-Mejía P; Sánchez-Castillo H; Velázquez-Martínez DN
    Pharmacol Biochem Behav; 2009 Jul; 93(1):25-30. PubMed ID: 19361543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeine as a model drug of abuse.
    Holtzman SG
    Trends Pharmacol Sci; 1990 Sep; 11(9):355-6. PubMed ID: 2238090
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug abuse as a problem of impaired control: current approaches and findings.
    Fillmore MT
    Behav Cogn Neurosci Rev; 2003 Sep; 2(3):179-97. PubMed ID: 15006292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Discrimination and the Analysis of Private Events.
    Kangas BD; Maguire DR
    Behav Anal (Wash D C); 2016 Nov; 16(4):159-168. PubMed ID: 27928551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys.
    Beardsley PM; Aceto MD; Cook CD; Bowman ER; Newman JL; Harris LS
    Exp Clin Psychopharmacol; 2004 Aug; 12(3):163-72. PubMed ID: 15301633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.